Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET™ Immunotherapy Drug Candidates
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET™ Immunotherapy Drug Candidates

Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it has licensed two TriNKET™ immunotherapy drug candidates to Celgene Corporation and its affiliates ("Celgene") for $12m each plus prospective...

Vast Therapeutics Announces Funding from Cystic Fibrosis Foundation for Further Development of BIOC51
Vast Therapeutics Announces Funding from Cystic Fibrosis Foundation for Further Development of BIOC51

Vast Therapeutics, Inc., (the Company), a preclinical stage pharmaceutical company focused on delivering nitric oxide (NO) in a synthetically derived powder-based form, announced today that the Company has received an...

Janssen Signs Results-Based Contract with Oklahoma Health Care Authority (OHCA) for its Long-Acting Injectable Schizophrenia Medicines
Janssen Signs Results-Based Contract with Oklahoma Health Care Authority (OHCA) for its Long-Acting Injectable Schizophrenia Medicines

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today a results-based contract for long-acting injectable schizophrenia medicines (LAIs) with the Oklahoma Health Care Authority (OHCA), which manages...

Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today the appointment of Timothy C. Rodell, M.D., FCCP, as Interim Chief Executive Officer,...

Adynxx Announces Notice Of Award For $5.7M In Federal Grant Funding
Adynxx Announces Notice Of Award For $5.7M In Federal Grant Funding

Adynxx, Inc., a clinical-stage biotechnology company focused on developing transformative therapies for pain and inflammatory diseases, today announced receipt of Notice of Award from the National Institute on Drug Abuse...

deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples
deCODE Genetics, An Amgen Subsidiary, And SomaLogic Announce Collaboration To Perform Large-Scale Protein Analysis Of Up To 40,000 Human Samples

deCODE genetics, an Amgen subsidiary, and SomaLogic, Inc. today announced a collaboration that brings together SomaLogic's expertise in human proteins with deCODE's expertise in human genetics. The collaboration...

Cirius Therapeutics Expands Board of Directors with Appointment of Elaine D. Sun
Cirius Therapeutics Expands Board of Directors with Appointment of Elaine D. Sun

Cirius Therapeutics, a clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, announced today that Elaine D. Sun,...

Aesthetic Surgery Journal Study Finds Google Favors Social Media Presence Over Academic Pedigree And Experience
Aesthetic Surgery Journal Study Finds Google Favors Social Media Presence Over Academic Pedigree And Experience

Findings from a recent study published in the Aesthetic Surgery Journal, one of the two official publications of the American Society for Aesthetic Plastic Surgery (ASAPS/The Aesthetic Society) demonstrates that patients...

Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in its inter partes review (IPR) proceedings and found all claims of Sanofi's Lantus (insulin...

Newly Published Case Series Demonstrates the Karius Test's Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections
Newly Published Case Series Demonstrates the Karius Test's Effectiveness for Monitoring Infections in Stem-Cell Transplant Patients at Risk of Infections

Karius, Inc., a life sciences company transforming infectious disease diagnostics with genomics, announced today the results of an ongoing clinical study of adult patients undergoing allogeneic hematopoietic stem cell...

Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943
Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced the initiation of dosing in the Phase 1 study of PN-10943, an oral, gut-restricted alpha-4-beta-7 integrin antagonist peptide in development for the potential...

Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®
Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan®

Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical-stage medical diagnostics company offering C-Scan®, the first and only preparation free capsule-based screening...

Biocompare Releases Documentary on "What Researchers Need to Know about Antibody Manufacturing"
Biocompare Releases Documentary on "What Researchers Need to Know about Antibody Manufacturing"

Biocompare, the leading online information resource for the life sciences, just released a must-see documentary entitled "What Researchers Need to Know about Antibody Manufacturing". This educational resource is the third...

Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications
Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications

Bruker Corporation and Mestrelab Research SL (www.mestrelab.com) today announced that they have entered into a strategic partnership to advance chemistry software that handles spectroscopic data and extracts and manages...

FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)

Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to baricitinib, which is being studied for the...

Ampio Updates Regulatory Status for Ampion
Ampio Updates Regulatory Status for Ampion

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today updates the regulatory status of Ampion.

Transporting the Light Killers: NUST MISiS and MIREA-Russian Technological University Collaborate to Create a Unique Tandem of Organic Molecules and Nanoparticles to Fight Cancer
Transporting the Light Killers: NUST MISiS and MIREA-Russian Technological University Collaborate to Create a Unique Tandem of Organic Molecules and Nanoparticles to Fight Cancer

A team of materials scientists from NUST MISiS together with a team of chemists from MIREA-Russian Technological University have managed to combine a photosensitizer molecule (a converter capable of transmitting the...

Oligonucleotide Synthesis Market Size Worth $3.9 Billion by 2025: Grand View Research, Inc.
Oligonucleotide Synthesis Market Size Worth $3.9 Billion by 2025: Grand View Research, Inc.

The global oligonucleotide synthesis market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of...

Microbial Discovery Group Obtains HACCP Food Ingredient Certification
Microbial Discovery Group Obtains HACCP Food Ingredient Certification

Microbial Discovery Group LLC (MDG) has expanded their HACCP scope which now includes food (human) ingredient. This has been part of their strategic plan and an important milestone in increasing their Bacillus fermentation...

With the Chinese API Market Growing, CPhI China Assists Enterprises with Transformation, Innovation, and Comprehensive Upgrading
With the Chinese API Market Growing, CPhI China Assists Enterprises with Transformation, Innovation, and Comprehensive Upgrading

The CPhI & P-MEC China 2019 organized by UBM EMEA and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) and co-organized by Shanghai UBM Sinoexpo International Exhibition...

Orexo Regains Rights to Zubsolv® in all Countries Outside the US
Orexo Regains Rights to Zubsolv® in all Countries Outside the US

Orexo AB (publ.), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces that the Company will regain the rights to Zubsolv (buprenorphine and naloxone sublingual...

WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange

WuXi AppTec Co., Ltd. ("WuXi AppTec" or "the Company"; Stock code: 603259.SH/2359.HK) today announced the listing of approximately 116 million H-shares on the Main Board of the Hong Kong Stock Exchange. Based on the offer...

Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that IBI305, a recombinant humanized anti-VEGF...

AIVITA Biomedical to Exhibit New ROOT OF SKIN™ MD Skincare Products at A4M World Congress
AIVITA Biomedical to Exhibit New ROOT OF SKIN™ MD Skincare Products at A4M World Congress

AIVITA Biomedical, Inc. today announced that it will be exhibiting at The American Academy of Anti-Aging Medicine (A4M) World Congress, taking place December 13-15 at the Venetian Palazzo Resort in Las Vegas, Nevada. There...

Growing Skin in the Lab for the Treatment of Advanced Wounds
Growing Skin in the Lab for the Treatment of Advanced Wounds

Though there are many medical devices that can be used in the care of advanced wounds, there is significant clinical research to support that biological therapies provide superior healing ability. IDTechEx Research has...

Rhode Island Headlines 

Massachusetts Headlines 

National